Lung transplant device LungFX won FDA approval Monday for centralized ex vivo lung perfusion, a technology that reconditions ...
3 School of Engineering and ICT, University of Tasmania, Hobart, Tasmania, Australia 4 School of Medicine, University of Tasmania, Hobart, Tasmania, Australia Objective To assess the performance of a ...
Objectives COVID-19 causes lung parenchymal and endothelial damage that lead to hypoxic acute respiratory failure (hARF). The influence of hARF severity on patients’ outcomes is still poorly ...
A non-rebreather mask is a special medical device that provides you with oxygen in emergencies. These masks help people who can still breathe on their own but need extra oxygen. Non-rebreather masks ...
Sanja Jelic, MD, is board-certified in sleep medicine, critical care medicine, pulmonary disease, and internal medicine. A PaO2 test measures oxygen pressure in arterial blood to help guide treatment ...
The SOFA-2 score included new definitions, new variables, and revised thresholds to categorize the severity of organ dysfunction in critical illness. The updates reflected changes in practice, ...
At 1 year after participants’ ICU stay for acute respiratory failure, mean DLCO was about 5% lower in those who had an ICU oxygenation target of 60 vs 90 mm Hg. Cognitive impairment levels among ...
The following is a summary of “Clinical Performance of Spo 2 /Fio 2 and Pao 2 /Fio 2 Ratio in Mechanically Ventilated Acute Respiratory Distress Syndrome Patients: A Retrospective Study,” published in ...
The following is a summary of “Prognostic value of PaO2/FiO2 ratio in predicting clinical outcomes in COVID-19 patients,” published in the June 2024 issue of Critical Care by Canto-Costal et al.
Clinical question: Do the anti-inflammatory and immunomodulatory effects of glucocorticoids decrease mortality among patients with severe community-acquired pneumonia (CAP)? Background: CAP remains a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results